Tohru Funahashi Selected Research

Adiponectin

1/2019	Adiponectin promotes muscle regeneration through binding to T-cadherin.
1/2018	Low muscle quality in Japanese type 2 diabetic patients with visceral fat accumulation.
8/2017	Significant Association of Serum Adiponectin and Creatine Kinase-MB Levels in ST-Segment Elevation Myocardial Infarction.
5/2017	Correlation of insulin resistance and motor function in spinal and bulbar muscular atrophy.
1/2017	Adiponectin association with T-cadherin protects against neointima proliferation and atherosclerosis.
1/2017	Westernization of lifestyle affects quantitative and qualitative changes in adiponectin.
1/2016	CDH13 Polymorphisms are Associated with Adiponectin Levels and Metabolic Syndrome Traits Independently of Visceral Fat Mass.
1/2015	Systemic arteriosclerosis and eating behavior in Japanese type 2 diabetic patients with visceral fat accumulation.
1/2015	Treatment-Induced Changes in Plasma Adiponectin Do Not Reduce Urinary Albumin Excretion in the Diabetes Prevention Program Cohort.
1/2015	ADIPOQ polymorphisms are associated with insulin resistance in Japanese women.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tohru Funahashi Research Topics

Disease

74	Obesity 08/2017 - 04/2002
64	Insulin Resistance 05/2017 - 02/2002
40	Type 2 Diabetes Mellitus (MODY) 11/2016 - 07/2002
37	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2016 - 02/2002
32	Hypoadiponectinemia 01/2017 - 09/2002
25	Atherosclerosis 01/2017 - 09/2002
23	Inflammation (Inflammations) 11/2016 - 06/2003
21	Hypertension (High Blood Pressure) 07/2014 - 11/2002
20	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 06/2005
19	Coronary Artery Disease (Coronary Atherosclerosis) 01/2014 - 02/2002
14	Body Weight (Weight, Body) 05/2014 - 10/2002
12	Neoplasms (Cancer) 06/2014 - 10/2003
10	Abdominal Obesity 03/2013 - 01/2003
9	Diabetes Mellitus 01/2017 - 11/2002
9	Glucose Intolerance 01/2017 - 06/2002
8	Hyperglycemia 07/2014 - 09/2003
8	Vascular Diseases (Vascular Disease) 04/2008 - 04/2002
7	Hypoxia (Hypoxemia) 01/2018 - 10/2006
6	Hypertriglyceridemia 07/2014 - 07/2003
6	Dyslipidemias (Dyslipidemia) 01/2014 - 01/2003
6	Hyperinsulinism (Hyperinsulinemia) 03/2012 - 10/2002
5	Heart Failure 01/2019 - 09/2005
5	Chronic Kidney Failure (Chronic Renal Failure) 07/2005 - 01/2002
4	Atherosclerotic Plaque (Atheroma) 01/2017 - 01/2005
4	Cardiomegaly (Heart Hypertrophy) 02/2014 - 12/2004
4	Sleep Apnea Syndromes (Sleep Apnea) 01/2014 - 05/2010
4	Myocardial Infarction 04/2009 - 10/2005
4	Overweight 12/2005 - 11/2002
3	Arteriosclerosis 01/2015 - 03/2004
3	Albuminuria 01/2015 - 08/2004
3	Hypertrophy 02/2014 - 12/2004
3	Acute Coronary Syndrome 01/2014 - 09/2006
3	Hyperuricemia 01/2014 - 06/2011
3	Breast Neoplasms (Breast Cancer) 01/2014 - 11/2003
3	Ischemia 09/2013 - 07/2004
3	Weight Loss (Weight Reduction) 09/2013 - 03/2012
3	Vascular Remodeling 04/2009 - 06/2002
3	Liver Diseases (Liver Disease) 01/2009 - 10/2007
3	Fibrosis (Cirrhosis) 05/2008 - 09/2007
3	Myocardial Ischemia (Ischemic Heart Diseases) 12/2006 - 10/2002
3	Chronic Renal Insufficiency 12/2006 - 05/2003
3	Liver Cirrhosis (Hepatic Cirrhosis) 09/2006 - 12/2003
3	Essential Hypertension 07/2005 - 09/2002
3	Proteinuria 04/2005 - 05/2003
3	Lipodystrophy 06/2004 - 04/2003
2	Vascular System Injuries 01/2017 - 06/2004
2	Non-alcoholic Fatty Liver Disease 01/2014 - 10/2007
2	Pancreatitis 01/2014 - 01/2010
2	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2014 - 10/2009
2	Gastroesophageal Reflux (GERD) 01/2014 - 01/2012
2	Prostatic Neoplasms (Prostate Cancer) 01/2014 - 09/2006
2	Peripheral Arterial Disease 01/2014 - 07/2012

Drug/Important Bio-Agent (IBA)

162	AdiponectinIBA 01/2019 - 01/2002
38	Insulin (Novolin)FDA Link 01/2017 - 06/2002
33	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 02/2002
29	AdipokinesIBA 06/2012 - 04/2002
22	Proteins (Proteins, Gene)FDA Link 08/2017 - 06/2002
14	LipidsIBA 07/2014 - 09/2003
14	Messenger RNA (mRNA)IBA 02/2014 - 04/2002
13	Triglycerides (Triacylglycerol)IBA 01/2016 - 11/2002
12	HDL CholesterolIBA 01/2016 - 11/2002
11	CholesterolIBA 05/2017 - 05/2003
9	CytokinesIBA 01/2017 - 01/2003
9	Biomarkers (Surrogate Marker)IBA 01/2014 - 11/2004
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2008 - 07/2002
8	C-Reactive ProteinIBA 01/2011 - 02/2003
7	Hormones (Hormone)IBA 01/2014 - 05/2002
6	LeptinIBA 01/2011 - 07/2003
5	Hemoglobins (Hemoglobin)IBA 05/2017 - 01/2008
5	HDL LipoproteinsIBA 01/2016 - 06/2007
5	Pioglitazone (Actos)FDA Link 01/2013 - 07/2005
4	AlbuminsIBA 01/2015 - 04/2005
4	ApolipoproteinsIBA 05/2014 - 11/2002
4	EnzymesIBA 01/2014 - 02/2004
4	Liraglutide FDA Link 01/2014 - 12/2011
4	Hypoglycemic Agents (Hypoglycemics)IBA 01/2012 - 04/2004
4	CreatinineIBA 08/2010 - 06/2005
4	Blood Proteins (Serum Proteins)IBA 04/2005 - 06/2002
4	Interleukin-6 (Interleukin 6)IBA 07/2004 - 01/2003
3	Blood Glucose (Blood Sugar)IBA 05/2017 - 09/2003
3	Apolipoproteins E (ApoE)IBA 01/2017 - 02/2008
3	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 05/2014 - 08/2003
3	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2014 - 12/2011
3	Uric Acid (Urate)IBA 09/2013 - 11/2002
3	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 06/2012 - 10/2009
3	LigandsIBA 03/2012 - 03/2007
3	Nicotinamide PhosphoribosyltransferaseIBA 03/2008 - 01/2005
3	ChemokinesIBA 02/2008 - 12/2005
3	SaltsIBA 09/2006 - 06/2004
3	Plasminogen InactivatorsIBA 12/2005 - 05/2004
3	Plasminogen Activator Inhibitor 1IBA 12/2005 - 05/2004
2	purineIBA 01/2018 - 09/2013
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 11/2016 - 12/2011
2	AutoantibodiesIBA 05/2014 - 11/2013
2	Angiotensin IIIBA 02/2014 - 05/2008
2	Growth Hormone (Somatotropin)IBA 01/2014 - 01/2012

Therapy/Procedure

10	Therapeutics 05/2014 - 07/2003
8	Glycemic Control 01/2014 - 01/2011
3	Highly Active Antiretroviral Therapy (HAART) 06/2004 - 04/2003
2	Percutaneous Coronary Intervention 08/2017 - 04/2009